Header

UZH-Logo

Maintenance Infos

Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study


Gayat, Etienne; Arrigo, Mattia; Littnerova, Simona; Sato, Naoki; Parenica, Jiri; Ishihara, Shiro; Spinar, Jindrich; Müller, Christian; Harjola, Veli-Pekka; Lassus, Johan; Miró, Òscar; Maggioni, Aldo P; AlHabib, Khalid F; Choi, Dong-Ju; Park, Jin Joo; Zhang, Yuhui; Zhang, Jian; Januzzi, James L; Kajimoto, Katsuya; Cohen-Solal, Alain; Mebazaa, Alexandre; GREAT Network (2018). Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. European Journal of Heart Failure, 20(2):345-354.

Abstract

AIMS Heart failure oral therapies (HFOTs), including beta-blockers (BB), renin-angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early administration of HFOTs may worsen patient's condition. We hypothesized that HFOTs at hospital discharge might be associated with better post-discharge survival.
METHODS AND RESULTS The study population was composed of 19 980 AHF patients from the GREAT registry. The primary and secondary outcomes were 90-day and 1-year all-cause mortality, respectively. Survival was estimated with univariate and covariate-adjusted Cox proportional hazards regression models for the whole population and after propensity-score matching. HFOTs at discharge were consistently associated with no excess mortality in the unadjusted and adjusted analyses of the whole and matched cohorts. In the matched cohort, BB and RASi at discharge were associated with lower 90-day mortality risks compared to the respective untreated groups [hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.46-0.69; and HR 0.53, 95% CI 0.42-0.66, respectively]. The favourable associations of BB and RASi at discharge with 90-day mortality were present in many subgroups including patients with reduced or preserved left ventricular ejection fraction and persisted up to 1 year after discharge. The combination of RASi and BB was associated with an even lower risk of death than RASi or BB alone.
CONCLUSIONS Administration of HFOTs at hospital discharge is associated with better survival of AHF patients.

Abstract

AIMS Heart failure oral therapies (HFOTs), including beta-blockers (BB), renin-angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early administration of HFOTs may worsen patient's condition. We hypothesized that HFOTs at hospital discharge might be associated with better post-discharge survival.
METHODS AND RESULTS The study population was composed of 19 980 AHF patients from the GREAT registry. The primary and secondary outcomes were 90-day and 1-year all-cause mortality, respectively. Survival was estimated with univariate and covariate-adjusted Cox proportional hazards regression models for the whole population and after propensity-score matching. HFOTs at discharge were consistently associated with no excess mortality in the unadjusted and adjusted analyses of the whole and matched cohorts. In the matched cohort, BB and RASi at discharge were associated with lower 90-day mortality risks compared to the respective untreated groups [hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.46-0.69; and HR 0.53, 95% CI 0.42-0.66, respectively]. The favourable associations of BB and RASi at discharge with 90-day mortality were present in many subgroups including patients with reduced or preserved left ventricular ejection fraction and persisted up to 1 year after discharge. The combination of RASi and BB was associated with an even lower risk of death than RASi or BB alone.
CONCLUSIONS Administration of HFOTs at hospital discharge is associated with better survival of AHF patients.

Statistics

Citations

Dimensions.ai Metrics
16 citations in Web of Science®
17 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 19 Feb 2019
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:February 2018
Deposited On:19 Feb 2019 15:45
Last Modified:25 Sep 2019 00:09
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1388-9842
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1002/ejhf.932
PubMed ID:28849606

Download